- Category
- Micro (2023-24)
- Udyam number
- UDYAM-UP-32-0023066

Novokon Pharmaceuticals Private Limited
About Novokon Pharmaceuticals Private Limited
Data last updated:
Novokon Pharmaceuticals Private Limited is a private limited company based in Greater Noida, Uttar Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 13 March 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U24304UP2019PTC114615. Its GSTIN is 09AAGCN4490G2Z6 (Uttar Pradesh). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1.5 Lakh. It is led by directors Krishna Kumar Pandey and Anil Kumar Pandey.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C – 1803 Divyansh Flora Gaur City – 2, Greater Noida, Uttar Pradesh, India – 201301.
As per the financials filed for FY 2025, the company reported a revenue of ₹64.59 Lakh, a decline of 45% compared to the previous year. For the same year it recorded a net loss of ₹10,311 (net margin -0.2%) and EBITDA of ₹7.6 Lakh (EBITDA margin 11.8%). Revenue has grown at a compounded annual rate (CAGR) of 9% over three years and 36% over five years.
The company has about 2 employees on its provident fund (EPFO) records.
Novokon Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-32-0023066).
Company details
Recognitions & Rankings of Novokon Pharmaceuticals
Contact details
Novokon Pharmaceuticals Private Limited's registered office is in Greater Noida, Uttar Pradesh. Its e-mail address is in the company report.
- Email
- Registered AddressC – 1803 Divyansh Flora Gaur City – 2, Greater Noida, Uttar Pradesh, India – 201301
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Novokon Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Novokon Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Novokon Pharmaceuticals Private Limited, buy the company report.
Financials of Novokon Pharmaceuticals Private Limited
FY 2025 filings availableNovokon Pharmaceuticals Private Limited reported revenue of ₹64.59 Lakh (down 45% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 45% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 36%. EBITDA fell 32% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹7.6 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹10,311 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 11.8% | ||||
| Net Profit Margin | -0.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Novokon Pharmaceuticals Private Limited, buy the company report.
Board of directors of Novokon Pharmaceuticals Private Limited
Novokon Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Krishna Kumar Pandey | Director | 03 Apr 2021 | 5 Years 7 Months | Current |
| Anil Kumar Pandey | Director | 13 Mar 2019 | 7 Years 8 Months | Current |
Peer comparison
Novokon Pharmaceuticals Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Akon Pharmaceuticals Private Limited | ₹65.2 Lakh (FY 2024) | 196.0% | Surat, Gujarat, India | |||
| Zecon Pharmaceuticals Private Limited | ₹65.17 Lakh (FY 2024) | -77.0% | Lucknow, Uttar Pradesh, India | |||
| Aironax Pharmaceuticals Private Limited | ₹65.15 Lakh (FY 2025) | 138.0% | Vadodara, Gujarat, India | |||
| Almonds Pharmaceuticals Private Limited | ₹65.07 Lakh (FY 2021) | 5.0% | Kolar, Karnataka, India | |||
| Kyriz Pharmaceuticals Private Limited | ₹64.74 Lakh (FY 2024) | Panchkula, Haryana, India | ||||
| Novokon Pharmaceuticals Private Limitedthis company | ₹64.59 Lakh (FY 2025) | -₹10,311 | -0.2% | -45.0% | 2 | Greater Noida, Uttar Pradesh, India |
| Organic Pharmaceuticals Private Limited | ₹64.39 Lakh (FY 2025) | 16.0% | New Delhi, Delhi, India | |||
| M.T Pharmaceuticals Private Limited | ₹64.22 Lakh (FY 2025) | -24.0% | Gorakhpur, Uttar Pradesh, India |
To see the full peer comparison of Novokon Pharmaceuticals Private Limited, buy the company report.
Auditor
Novokon Pharmaceuticals Private Limited is audited by VIJAY PAREEK & CO for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| VIJAY PAREEK & CO | FY 2020 | 021391C |
Shareholding
The shareholding of Novokon Pharmaceuticals Private Limited is on record for FY 2020, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2020 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Novokon Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Novokon Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Novokon Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Novokon Pharmaceuticals Private Limited has a workforce of 2 employees on its EPFO records as of Aug 2023, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2023-24 | 2 |
| FY 2022-23 |
To see the full employee and EPFO history of Novokon Pharmaceuticals Private Limited, buy the company report.
GST
Novokon Pharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAGCN4490G2Z6 | Uttar Pradesh | Active | 16 Dec 2019 |
To see the full GST registrations and return filing status of Novokon Pharmaceuticals Private Limited, buy the company report.
Recent activity
Novokon Pharmaceuticals Private Limited has 4 board changes on record since 2019: 2 appointments and 2 cessations. The latest: Naveen Kumar Srivastava ceased to be Director on 30 Apr 2021.
Frequently asked questions
Novokon Pharmaceuticals is an active private limited company based in Greater Noida, Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 13 March 2019 (7+ years old) and is registered under CIN U24304UP2019PTC114615.
Novokon Pharmaceuticals has 2 current directors:
- Krishna Kumar Pandey - Director
- Anil Kumar Pandey - Director
The latest financial statements of Novokon Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Novokon Pharmaceuticals is 09AAGCN4490G2Z6, registered in Uttar Pradesh. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Novokon Pharmaceuticals is U24304UP2019PTC114615. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Novokon Pharmaceuticals was incorporated on 13 March 2019, making it 7+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Novokon Pharmaceuticals by revenue are Akon Pharmaceuticals Private Limited, Zecon Pharmaceuticals Private Limited, Aironax Pharmaceuticals Private Limited, Almonds Pharmaceuticals Private Limited, Kyriz Pharmaceuticals Private Limited and 2 more, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Naveen Kumar Srivastava ceased to be Director on 30 Apr 2021. Sunil Kumar Gupta ceased to be Director on 30 Apr 2021. Krishna Kumar Pandey was appointed as Director on 03 Apr 2021. Novokon Pharmaceuticals has 4 board changes on record in total.
Yes, Novokon Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-32-0023066).
The registered office of Novokon Pharmaceuticals is at C – 1803 Divyansh Flora Gaur City – 2, Greater Noida, Uttar Pradesh, India – 201301.
Novokon Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

